Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 5,480 | 13,219 | 34,202 | 14,636 | 33,900 |
| Gross Profit | 5,480 | 13,219 | 34,202 | 14,636 | 33,900 |
| Operating Expenses | 45,955 | 45,352 | 39,397 | 41,363 | 30,692 |
| Operating Income | -40,475 | -32,133 | -5,195 | -26,727 | 3,208 |
| Other Income | 218 | 236 | 238 | 85 | 48 |
| Pre-tax Income | -40,257 | -31,897 | -4,957 | -26,642 | 3,256 |
| Income Tax | N/A | N/A | N/A | 22 | -448 |
| Net Income Continuous | -40,257 | -31,897 | -4,957 | -26,664 | 3,704 |
| Net Income | $-40,257 | $-31,897 | $-4,957 | $-26,664 | $3,704 |
| EPS Basic Total Ops | -1.07 | -0.85 | -0.13 | -0.77 | 0.11 |
| EPS Basic Continuous Ops | -1.07 | -0.85 | -0.13 | -0.76 | 0.11 |
| EPS Diluted Total Ops | -1.07 | -0.85 | -0.13 | -0.76 | 0.10 |
| EPS Diluted Continuous Ops | -1.07 | -0.85 | -0.13 | -0.76 | 0.10 |
| EBITDA(a) | $-39,316 | $-31,206 | $-4,653 | $-26,239 | $3,661 |